Green mamba peptide found to reduce symptoms of kidney disease in mice

June 20, 2017 by Bob Yirka, Medical Xpress report
The green mamba, Dendroaspis angusticeps. Credit: C. Vanbellingen

(Medical Xpress)—A team of researchers from France, Germany and Belgium has found that giving a peptide found in green mamba venom to mice with a kidney disease led to reduced symptoms. In their paper published in Proceedings of the National Academy of Sciences, the group describes how test mice with polycystic kidney disease (PKD) saw reduced symptoms when given the peptide.

PKD is a genetic disorder that causes kidney problems for people (and mice)—fluid-filled cysts develop, which can damage the kidneys leading to renal failure. Prior research has shown that, like many other disorders, PKD is actually a family of ailments caused by different problems in the genome. PKD is not curable and is treated with drugs called vasopressin antagonists that block the type 2 that cause the cysts. But such drugs have negative side effects, one of which is liver damage. In this new effort, the researchers studied the venom from a poisonous African snake because snake venom tends to do its destructive work by causing neural problems, some of which involve .

To learn more about possible benefits of green mamba venom, the researchers isolated a peptide called mambaquaretin-1, which was known to block cell receptors. They gave it to six mice that had been genetically altered to have PKD over the course of 99 days. The mice were monitored to see if they suffered any ill effects from the peptide, and to find out if it had a positive impact on the kidney cysts in the mice. The researchers report that all of the mice given the peptide (as opposed to those given just salt water as a control) experienced improved kidney function and no side effects. They also found that the number of cysts in the treated was reduced by approximately one-third and total kidney area made up of cysts was lessened by 47 percent. A closer look suggested that the peptide caused such improvements by blocking the type-2 vasopressin receptor, just as current drugs are meant to do.

More research will have to be done, of course, to figure out if the peptide is safe for use in people and if it offers the same benefits, but as of now, the team is optimistic. They also plan to look into using the peptide to treat other ailments.

Explore further: Study finds four genes linked to cystic diseases of the liver and kidney

More information: Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1620454114 , http://www.pnas.org/content/early/2017/06/13/1620454114

Abstract
Polycystic kidney diseases (PKDs) are genetic disorders that can cause renal failure and death in children and adults. Lowering cAMP in cystic tissues through the inhibition of the type-2 vasopressin receptor (V2R) constitutes a validated strategy to reduce disease progression. We identified a peptide from green mamba venom that exhibits nanomolar affinity for the V2R without any activity on 155 other G-protein–coupled receptors or on 15 ionic channels. Mambaquaretin-1 is a full antagonist of the V2R activation pathways studied: cAMP production, beta-arrestin interaction, and MAP kinase activity. This peptide adopts the Kunitz fold known to mostly act on potassium channels and serine proteases. Mambaquaretin-1 interacts selectively with the V2R through its first loop, in the same manner that aprotinin inhibits trypsin. Injected in mice, mambaquaretin-1 increases in a dose-dependent manner urine outflow with concomitant reduction of urine osmolality, indicating a purely aquaretic effect associated with the in vivo blockade of V2R. CD1-pcy/pcy mice, a juvenile model of PKD, daily treated with 13 μ

Related Stories

Study finds four genes linked to cystic diseases of the liver and kidney

April 6, 2017
Yale researchers are studying kidney and liver diseases to determine which genes are involved in the formation of cysts.

Peptide targeting senescent cells restores stamina, fur, and kidney function in old mice

March 23, 2017
Regular infusions of a peptide that can selectively seek out and destroy broken-down cells that hamper proper tissue renewal, called senescent cells, showed evidence of improving healthspan in naturally-aged mice and mice ...

Researchers find hormone vasopressin involved in jet lag

October 4, 2013
(Medical Xpress)—A team of researchers from several research centers in Japan has together found what appears to be a connection between the hormone vasopressin and jet-lag. In their paper published in the journal Science, ...

New treatment for polycystic kidney disease

June 3, 2015
A new technique for treating polycystic kidney disease has been identified by researchers at The University of Manchester and UCL.

Researchers develop potential treatment for fatal kidney disease

February 16, 2017
Researchers at UT Southwestern Medical Center, working with a California biotech firm, have developed a potential drug to treat polycystic kidney disease - an incurable genetic disease that often leads to end-stage kidney ...

Recommended for you

LincRNAs identified in human fat tissue

June 21, 2018
A large team of researchers from the U.S. and China has succeeded in identifying a number of RNA fragments found in human fat tissue. In their paper published in the journal Science Translational Medicine the group describes ...

Scientists solve the case of the missing subplate, with wide implications for brain science

June 21, 2018
The disappearance of an entire brain region should be cause for concern. Yet, for decades scientists have calmly maintained that one brain area, the subplate, simply vanishes during the course of human development. Recently, ...

Key molecule of aging discovered

June 21, 2018
Every cell and every organism ages sooner or later. But why is this so? Scientists at the German Cancer Research Center in Heidelberg have now discovered for the first time a protein that represents a central switching point ...

Compound made inside human body stops viruses from replicating

June 20, 2018
The newest antiviral drugs could take advantage of a compound made not by humans, but inside them. A team of researchers has identified the mode of action of viperin, a naturally occurring enzyme in humans and other mammals ...

Research reveals zero proof probiotics can ease your anxiety

June 20, 2018
If you're expecting probiotics to reduce your anxiety, it might be time to put down that yogurt spoon—or supplement bottle—and call a professional instead.

Long-term estrogen therapy changes microbial activity in the gut, study finds

June 20, 2018
Long-term therapy with estrogen and bazedoxifene alters the microbial composition and activity in the gut, affecting how estrogen is metabolized, a new study in mice found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.